Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |